2bPrecise

Company Overview

Snapshot

Founded in October 2015 by Assaf Halevy, 2bPrecise operates with 11–50 employees. The company was acquired by AccessDX Holdings in August 2021, marking a significant milestone in its journey.

Business overview

2bPrecise provides a platform that integrates actionable genomic information with existing patient data directly into clinicians' workflows within electronic health records. This technology allows for semantically stored, research-ready data to be accessed for future study, offering powerful clinical decision-making tools at the point of care. The company's comprehensive suite of capabilities is designed to accelerate precision medicine integration from both genomic and machine-learning environments, enabling faster diagnostic decisions and identification of effective treatments. 2bPrecise serves the healthcare industry, focusing on hospitals, healthcare providers, and patients, operating within the Health Tech & Life Sciences sector, specifically in Digital Healthcare and Medical Decision Support.

Strategic signal

In May 2022, 2bPrecise was recognized as the "Best Overall Genomics Company" in the 2022 MedTech Breakthrough Awards Program. This award validates the company's innovative approach and leadership in the genomics space, signaling its continued influence and strong market position even after its acquisition.

Company Intelligence Q&A

When was 2bPrecise acquired and by whom?

2bPrecise was acquired by AccessDX Holdings in August 2021.

What recognition did 2bPrecise receive in 2022?

In May 2022, 2bPrecise was named the "Best Overall Genomics Company" in the 2022 MedTech Breakthrough Awards Program.

Did 2bPrecise partner with Epic App Orchard?

Yes, in November 2021, 2bPrecise joined the Epic App Orchard to integrate its precision medicine insights into the point of care.

What was the collaboration between 2bPrecise and Mayo Clinic?

In June 2017, 2bPrecise collaborated with Mayo Clinic on genomics care protocols.